Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 809Neoplasms, Plasma Cell 111Recurrence 109Immunoglobulin Light-chain Amyloidosis 50Neoplasms 33Amyloidosis 21Smoldering Multiple Myeloma 15Renal Insufficiency 13Paraproteinemias 12Lymphoma, Non-Hodgkin 12Hematologic Diseases 11Leukemia, Plasma Cell 10Lymphoma 9Plasmacytoma 8Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Disease 6Blood Protein Disorders 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Hodgkin Disease 5Neoplasm, Residual 4Nausea 4Myelodysplastic Syndromes 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Disease Progression 4Chromosome 17 deletion 4

Interventions

Thalidomide 1Melphalan 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endocrine System Diseases × Dexamethasone × Plasma cell × Clear all
NCT01548573 2017-06-14

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

University of Iowa

Phase 2 Terminated
19 enrolled 7 charts
Plasma cell

Amyloidosis, Endocrine System Diseases, Multiple Myeloma, Paraproteinemias, Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡